Fundraising Fox
Lucence
Singapore, SG · Founded 2016 · 105 employees on LinkedIn · 4 known investors
Find your way into Lucence
Sign up to find every way you can get introduced to Lucence
- Your email: who you already know at Lucence, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lucence team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.
Investors · 4
How we know: Openspace Ventures's portfolio page · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$20M disclosed across 1 round · 2019
- $20MSeries ANov 2019 · 4 sources
IHH Healthcare (lead), Heliconia Capital, SGInnovate
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Lucence do?
- Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.
- Who are Lucence's investors?
- Lucence's investors include Openspace Ventures, Heliconia Capital, SGInnovate.
- How much funding has Lucence raised?
- Lucence has disclosed $20M raised across 1 round.
- Where is Lucence headquartered?
- Lucence is headquartered in Singapore, SG.